Benchmark Upgrades Nephros (NEPH) to Speculative Buy

Benchmark analyst Robert Wasserman upgraded Nephros (NASDAQ: NEPH) from Hold to Speculative Buy with a price target of $5.00.

For an analyst ratings summary and ratings history on Nephros click here. For more ratings news on Nephros click here.

Shares of Nephros closed at $3.02 yesterday.

You May Also Be Interested In

• Northland Upgrades Hyliion Holdings (HYLN) to Outperform 'on Improved Visibility to KARNO Commercialization'
• JPMorgan Upgrades Kolmar Korea Co Ltd (161890:KS) to Overweight
• Ladenburg Thalmann Upgrades ONE Gas Inc. (OGS) to Buy